FR2636M - Agents thérapeutiques a base de 4,4-diphényl-2-(tert.-butylamino)-butane. - Google Patents

Agents thérapeutiques a base de 4,4-diphényl-2-(tert.-butylamino)-butane.

Info

Publication number
FR2636M
FR2636M FR931831A FR931831A FR2636M FR 2636 M FR2636 M FR 2636M FR 931831 A FR931831 A FR 931831A FR 931831 A FR931831 A FR 931831A FR 2636 M FR2636 M FR 2636M
Authority
FR
France
Prior art keywords
butylamino
butane
diphenyl
tert
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR931831A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recip AB
Original Assignee
Recip AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3832460A external-priority patent/GB923942A/en
Application filed by Recip AB filed Critical Recip AB
Priority to FR931831A priority Critical patent/FR2636M/fr
Application granted granted Critical
Publication of FR2636M publication Critical patent/FR2636M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR931831A 1960-11-08 1963-04-17 Agents thérapeutiques a base de 4,4-diphényl-2-(tert.-butylamino)-butane. Expired FR2636M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR931831A FR2636M (fr) 1960-11-08 1963-04-17 Agents thérapeutiques a base de 4,4-diphényl-2-(tert.-butylamino)-butane.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3832460A GB923942A (en) 1960-11-08 1960-11-08 New compounds, processes for preparing them and pharmaceutical compositions containing them
FR931831A FR2636M (fr) 1960-11-08 1963-04-17 Agents thérapeutiques a base de 4,4-diphényl-2-(tert.-butylamino)-butane.

Publications (1)

Publication Number Publication Date
FR2636M true FR2636M (fr) 1964-07-06

Family

ID=10402729

Family Applications (1)

Application Number Title Priority Date Filing Date
FR931831A Expired FR2636M (fr) 1960-11-08 1963-04-17 Agents thérapeutiques a base de 4,4-diphényl-2-(tert.-butylamino)-butane.

Country Status (5)

Country Link
US (1) US3371014A (enExample)
CH (1) CH415662A (enExample)
DE (1) DE1170417B (enExample)
FR (1) FR2636M (enExample)
SE (1) SE300218B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492933A (en) * 1993-10-08 1996-02-20 Sepracor, Inc. Methods and compositions for treating urinary incontinence and other disorders using optically pure R-terodiline and hydroxylated derivatives thereof
SE0103668D0 (sv) * 2001-11-02 2001-11-02 Astrazeneca Ab Method for the treatment of overactive blader
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
ATE551059T1 (de) * 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
DE102007039744A1 (de) * 2007-04-18 2008-10-23 Repa Boltersdorf Gmbh Pulper zum Recyceln eines Gemenges
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN119060040A (zh) 2019-01-18 2024-12-03 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Also Published As

Publication number Publication date
DE1170417B (de) 1964-05-21
CH415662A (de) 1966-06-30
SE300218B (enExample) 1968-04-22
US3371014A (en) 1968-02-27

Similar Documents

Publication Publication Date Title
FR2636M (fr) Agents thérapeutiques a base de 4,4-diphényl-2-(tert.-butylamino)-butane.
FR1320M (fr) Agents pharmaceutiques a base de benzenedisulfamides.
FR1038M (fr) Médicament a base d'aspirine.
FR2012M (fr) Médicament a base d'un nouvel heptapeptide.
FR3405M (fr) Médicament a base d'une sulfométhyl-polymyxine.
FR2221M (fr) Nouveaux médicaments a base de 17 α-méthyl stéroides servant d'agents progestinogenes.
FR2239M (fr) Médicaments a base de dialcoyl-aminoalcoyl-pipéridines.
FR2231M (fr) Médicament a base de nouvelles dibenzothiéphinnes.
FR1014M (fr) Compositions médicinales a base de 6-aryl-2,4,7-triaminoptéridine.
FR2721M (fr) Médicament a base de dicarbamates d'haloalkyl-1,3-propanediols.
FR2415M (fr) Médicament a base d'éthanolamines substituées.
FR1504M (fr) Médicament a base de dérivé du thiaxanthene.
FR1144M (fr) Médicament a base de 1.2-diaryl-3.5-dioxo-pyrazolidines.
FR1135M (fr) 1,4-di-(méthane-sulfonate) de butane-tétrol-1,2,3,4.
FR290M (fr) Composition médicamenteuses a base de diphényl-1,1 amino-2 propane.
FR2992M (fr) Médicament a base de 2.4-diamino-6-hydroxyméthyl-7.8-dihydro-ptéridine.
FR2577M (fr) Médicament a base de naphtyl-amino-imidazoline.
FR1075M (fr) Médicament a base de 4-nitro-3-hydroxy-thiofene-2-carboxylate de méthyle.
FR2341M (fr) Analgésique a base de 3-n-morpholyl-1,2,3-benzotriazinone-(4).
FR2294M (fr) Composition a base de sorbitol.
FR3235M (fr) Médicament a base de sulfanilamido-pyrimidine.
FR1077M (fr) Compositions a base de tétracyclines.
FR168M (fr) Composition progestinogene a base de 17-acétate de 6alpha-méthyl-17alpha-hydroxy-progestérone.
FR1468M (fr) Médicament a base de polypeptide.
FR236M (fr) Antidiabétique a base de n-p-toluenesulfonyl-n-n-butoxyurée.